Pfizer Ltd. stands out in profitability metrics with a high ROE and EBITDA margin compared to its peers, though it has a high valuation. Companies like Cipla and Dr. Reddy's demonstrate strong growth potential and better valuation metrics, making them attractive picks in the sector.

• • Pfizer leads in ROE and EBITDA margin, indicating strong profitability.
• • Cipla and Dr. Reddy's are attractive growth and value picks.
• • Sun Pharmaceutical appears overvalued with low growth.
• • Divi's Laboratories shows signs of weakness with declining revenue.